000 | 01580 a2200397 4500 | ||
---|---|---|---|
005 | 20250516013751.0 | ||
264 | 0 | _c20110314 | |
008 | 201103s 0 0 eng d | ||
022 | _a1460-2091 | ||
024 | 7 |
_a10.1093/jac/dkq252 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJones, Ronald N | |
245 | 0 | 0 |
_aCeftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study. _h[electronic resource] |
260 |
_bThe Journal of antimicrobial chemotherapy _cNov 2010 |
||
300 |
_aiv17-31 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aCephalosporins _xpharmacology |
650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
650 | 0 | 4 | _aEurope |
650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
650 | 0 | 4 |
_aGram-Positive Cocci _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aPopulation Surveillance _xmethods |
650 | 0 | 4 |
_aSkin Diseases, Bacterial _xdrug therapy |
650 | 0 | 4 |
_aSoft Tissue Infections _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aCeftaroline |
700 | 1 | _aMendes, Rodrigo E | |
700 | 1 | _aSader, Helio S | |
773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 65 Suppl 4 _gp. iv17-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkq252 _zAvailable from publisher's website |
999 |
_c20408009 _d20408009 |